57
In band
Moving averages
SMA 200$73.54+201.50%
Company profile
Moderna, Inc., a biotechnology company, develops messenger RNA-based vaccines and therapies for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and autoimmune diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$85.33B
P/E ratioNone
EPS$-7.98
Beta1.095
Dividend yield0.00%
52-week high$227.46
52-week low$22.28
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
TECH
Bio-Techne Corp
RSI 57
IBRX
ImmunityBio Inc
RSI 44
BMRN
Biomarin Pharmaceutical Inc
RSI 55
VKTX
Viking Therapeutics Inc
RSI 48
TARS
Tarsus Pharmaceuticals Inc
RSI 55
ATAI
ATAI Life Sciences N.V.
RSI 62
RSI alerts for MRNA
An email when MRNA closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:33 PM EDT